Original Article
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:33
.
(01 April 2026)
PDF
Full Text
(123)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
There is limited research focusing on recipients without cirrhosis, especially in East Asia. This study demonstrates that liver transplantation for non-cirrhotic hepatocellular carcinoma has a poor prognosis compared with cirrhotic hepatocellular carcinoma.
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:34
.
(01 April 2026)
The study provides useful information on the relationship between time-in-range and organ/space surgical site infection after pancreatectomy. The findings indicate that a time-in-range <75% during the first week after pancreatectomy is a significant risk factor for organ/space surgical site infection.
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:35
.
(01 April 2026)
The first report of human liver local immune microenvironment changes during rapid regeneration induced by ALPPS. THBS1+ tissue monocytes recruit by C5a are significantly enriched in FLR resulting a shift from a macrophage-enriched to monocyte-enriched local immune environment, promoting hepatocyte proliferation via EREG- EGFR interactions.
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:36
.
(01 April 2026)
This meta-analysis assesses the impact of adjuvant therapies (chemotherapy, radiotherapy, and chemoradiotherapy) on survival outcomes in resectable gallbladder cancer. The results suggest that chemoradiotherapy is associated with improved survival, especially in patients with high-risk features, highlighting the need for personalized treatment strategies.
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:37
.
(01 April 2026)
PDF
Full Text
(44)
Reporting Checklist
Trial Protocol
Data Sharing Statement
Peer Review File
COI Form
Open Access
HAIC combined with bevacizumab and toripalimab yielded encouraging outcomes as a first-line treatment for advanced BTCs in terms of ORR, PFS, OS, and an acceptable safety profile. Therefore, the triple combination therapy may be an improved first-line treatment for advanced BTC.
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:38
.
(01 April 2026)
Some patients apparently-fit for surgery after PVE are going to hepatic resection with lower hepatic functional reserve and show altered functional regenerative capacities compared with patients without PVE. Special attention should be paid to such patients in the perioperative period.
Factors associated with textbook outcome after robotic-assisted pancreatoduodenectomy: a single surgeon’s retrospective cohort
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:39
.
(01 April 2026)
In a single-surgeon cohort of RPD patients, TO was achieved in 57.0% of all patients and in 63.2% after surgeon’s learning curve. Surgeon’s learning curve, ASA score, concomitant diabetes, and dilated pancreatic duct (>3mm) were independently associated with TO.
Editorial Commentary
First randomized controlled trial comparing stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: lessons and key considerations for interpretation of results
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:40
.
(01 April 2026)
Perioperative antibiotic prophylaxis in pancreatoduodenectomy: toward a new standard, but questions remain
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:41
.
(01 April 2026)
Phenotypic personalized tacrolimus dosing: a step toward precision immunosuppression in liver transplantation
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:42
.
(01 April 2026)
Should nasogastric enteral feeding become a standard escalation to reverse malnutrition in liver transplant candidates?
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:43
.
(01 April 2026)
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:44
.
(01 April 2026)
Hypovolemic phlebotomy and low central venous pressure: a paradigm shift in liver surgery?
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:45
.
(01 April 2026)
Balancing safety and outcomes in minimally invasive liver resection: insights from the PRESSURE trial
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:46
.
(01 April 2026)
Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:47
.
(01 April 2026)
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:48
.
(01 April 2026)
Revisiting the two-stage hepatectomy and hepatic arterial infusion chemotherapy for colorectal liver metastases: insights and long-term outcomes from a large cohort
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:49
.
(01 April 2026)
Fabricating transplantable, vascularized, and cholangiogenic bioartificial livers via three-dimensional bioprinting: a promising therapeutic strategy for liver failure
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:50
.
(01 April 2026)
How does obesity develop—and are specific foods to blame?
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:51
.
(01 April 2026)
Metabolic syndrome and cholangiocarcinoma: large numbers, small risks, but big implications
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:52
.
(01 April 2026)
Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:53
.
(01 April 2026)
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resistance deciphering
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:54
.
(01 April 2026)
Treat-to-target in pancreatic exocrine insufficiency: moving from symptom control to nutrition outcomes
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:55
.
(01 April 2026)
Editorial
Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:56
.
(01 April 2026)
Letter to the Editor
A rare case of giant paraganglioma in the first porta hepatis area associated with neurofibromatosis type 1
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:57
.
(01 April 2026)
Pancreatobiliary maljunction accompanied by synchronous carcinomas
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:58
.
(01 April 2026)
Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:59
.
(01 April 2026)
Advancing the enhanced recovery after surgery paradigm in liver transplantation: evidence-based strategies for a comprehensive care continuum
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:60
.
(01 April 2026)
Robotic-assisted hepatopancreatoduodenectomy for intraductal papillary neoplasm of the bile duct: future approach for minimally invasive biliary surgery
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:61
.
(01 April 2026)
Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:62
.
(01 April 2026)
Images in Clinical Medicine
Pancreatic adenosquamous carcinoma mimicking autoimmune pancreatitis
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:63
.
(01 April 2026)
Erratum
Erratum: De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial
HepatoBiliary Surgery and Nutrition
2026;
15
(2)
:64
.
(01 April 2026)
